1. In Vivo
  2. >>Global Vision

China Drug Price Negotiations: Another Race To The Bottom？

Competition, Coverage and Cost Control

 
• By Brian Yang

With the fourth quarter just around the corner, China's closely-watched annual drug reimbursement and prices negotiations are entering a key final stage. But will applicants need to be more strategic than expedient?

CHINA DRUG PRICE NEGOTIATIONS: ANOTHER RACE TO BOTTOM?
2011 CHINA DRUG PRICE NEGOTIATIONS COULD BECOME ANOTHER RACE TO BOTTOM • Source: Shutterstock

As China’s annual drug reimbursement talks kick into high gear and enter the final key stage before formal discussions, many will be watching for any signs of unusually aggressive price-cutting this year. Many fear another race to the bottom for pharma companies large or small, domestic or international.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Global Vision

More from In Vivo